Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 3/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8722981 | 0.84 | CTSK (0.53) | CTSKPSMB5 | |
| SCHEMBL29813236 | 0.83 | CTSK (0.53) | CTSKPSMB5 | |
| SCHEMBL8726195 | 0.82 | NPC1 (0.38) | TDP1PPARAPPARG | |
| SCHEMBL9088141 | 0.80 | HDAC1 (0.49) | MAPTTDP1POLB | |
| SCHEMBL8721920 | 0.80 | DHFR (0.34) | TDP1PPARAPPARG | |
| SCHEMBL8723006 | 0.79 | DHFR (0.33) | TDP1PPARAPPARG | |
| SCHEMBL30999385 | 0.78 | CTSK (0.53) | PPARACTSKPSMB5 | |
| SCHEMBL7904398 | 0.78 | CTSK (0.51) | CTSKPSMB5 | |
| SCHEMBL13570900 | 0.78 | SYK (0.55) | MAPTPPARACTSKPPARG | |
| SCHEMBL9819558 | 0.78 | SYK (0.55) | MAPTPPARACTSKPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998035982-A1 | COMPOUNDS FOR USE IN ADEPT | ZENECA LIMITED (GB) | 1998-08-20 | — | — | WO | disclosed |